-
1
-
-
80054767730
-
Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: Roles for fumarate in KEAP1 succination and Nrf2 signaling
-
1:CAS:528:DC%2BC3MXhtlKrtrfM 22014577
-
Adam, J., et al. 2011. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: Roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20(4): 524-537.
-
(2011)
Cancer Cell
, vol.20
, Issue.4
, pp. 524-537
-
-
Adam, J.1
-
2
-
-
7944226627
-
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
-
1:CAS:528:DC%2BD2cXptlykt78%3D 15533718
-
Altenberg, B., and K.O. Greulich. 2004. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84(6): 1014-1020.
-
(2004)
Genomics
, vol.84
, Issue.6
, pp. 1014-1020
-
-
Altenberg, B.1
Greulich, K.O.2
-
3
-
-
84889591862
-
Metabolomics in cancer biomarker discovery: Current trends and future perspectives
-
1:CAS:528:DC%2BC3sXhsFGnsLrK 24091079
-
Armitage, E.G., and C. Barbas. 2014. Metabolomics in cancer biomarker discovery: Current trends and future perspectives. Journal of Pharmaceutical and Biomedical Analysis 87: 1-11.
-
(2014)
Journal of Pharmaceutical and Biomedical Analysis
, vol.87
, pp. 1-11
-
-
Armitage, E.G.1
Barbas, C.2
-
4
-
-
68949092126
-
Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2
-
1:CAS:528:DC%2BD1MXhtV2qurzO 19033423
-
Baumann, F., et al. 2009. Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncology 11(4): 368-380.
-
(2009)
Neuro Oncology
, vol.11
, Issue.4
, pp. 368-380
-
-
Baumann, F.1
-
5
-
-
33745519159
-
Lactate stimulates endothelial cell migration
-
Beckert, S., et al. 2006. Lactate stimulates endothelial cell migration. Wound Repair and Regeneration 14(3): 321-324.
-
(2006)
Wound Repair and Regeneration
, vol.14
, Issue.3
, pp. 321-324
-
-
Beckert, S.1
-
6
-
-
84892860969
-
A review of applications of metabolomics in cancer
-
1:CAS:528:DC%2BC3sXht1ejur7E 24958139
-
Beger, R.D. 2013. A review of applications of metabolomics in cancer. Metabolites 3(3): 552-574.
-
(2013)
Metabolites
, vol.3
, Issue.3
, pp. 552-574
-
-
Beger, R.D.1
-
7
-
-
79953700548
-
Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia
-
1:CAS:528:DC%2BC3MXkslagurc%3D 21454467
-
Boissel, N., et al. 2011. Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. Blood 117(13): 3696-3697.
-
(2011)
Blood
, vol.117
, Issue.13
, pp. 3696-3697
-
-
Boissel, N.1
-
8
-
-
84864106022
-
Determining in vivo phosphorylation sites using mass spectrometry
-
Chapter 18: p. Unit18 19 1-27
-
Breitkopf, S.B., and J.M. Asara 2012. Determining in vivo phosphorylation sites using mass spectrometry. Current Protocols in Molecular Biology. Chapter 18: p. Unit18 19 1-27.
-
(2012)
Current Protocols in Molecular Biology
-
-
Breitkopf, S.B.1
Asara, J.M.2
-
9
-
-
77957122174
-
The engine driving the ship: Metabolic steering of cell proliferation and death
-
1:CAS:528:DC%2BC3cXhtFylur3L 20861880
-
Buchakjian, M.R., and S. Kornbluth. 2010. The engine driving the ship: Metabolic steering of cell proliferation and death. Nature Reviews Molecular Cell Biology 11(10): 715-727.
-
(2010)
Nature Reviews Molecular Cell Biology
, vol.11
, Issue.10
, pp. 715-727
-
-
Buchakjian, M.R.1
Kornbluth, S.2
-
10
-
-
84868019043
-
Cancer cell metabolism: One hallmark, many faces
-
1:CAS:528:DC%2BC38XhsFagtLrJ 23009760
-
Cantor, J.R., and D.M. Sabatini. 2012. Cancer cell metabolism: One hallmark, many faces. Cancer Discovery 2(10): 881-898.
-
(2012)
Cancer Discovery
, vol.2
, Issue.10
, pp. 881-898
-
-
Cantor, J.R.1
Sabatini, D.M.2
-
11
-
-
84869082905
-
Serine is a natural ligand and allosteric activator of pyruvate kinase M2
-
1:CAS:528:DC%2BC38XhsV2rsL7K 23064226
-
Chaneton, B., et al. 2012. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491(7424): 458-462.
-
(2012)
Nature
, vol.491
, Issue.7424
, pp. 458-462
-
-
Chaneton, B.1
-
12
-
-
79957774646
-
Pyruvate carboxylase is required for glutamine-independent growth of tumor cells
-
1:CAS:528:DC%2BC3MXntVGqur4%3D
-
Cheng, T., et al. 2011. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proceedings of the National Academy of Sciences USA 108(21): 8674-8679.
-
(2011)
Proceedings of the National Academy of Sciences USA
, vol.108
, Issue.21
, pp. 8674-8679
-
-
Cheng, T.1
-
13
-
-
79751530369
-
The prognostic impact and stability of isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
-
1:CAS:528:DC%2BC3MXhs1amsrY%3D 21079611
-
Chou, W.C., et al. 2011. The prognostic impact and stability of isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia. Leukemia 25(2): 246-253.
-
(2011)
Leukemia
, vol.25
, Issue.2
, pp. 246-253
-
-
Chou, W.C.1
-
14
-
-
79955547561
-
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
-
1:CAS:528:DC%2BC3MXktFahs74%3D 21460794
-
Chowdhury, R., et al. 2011. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Reports 12(5): 463-469.
-
(2011)
EMBO Reports
, vol.12
, Issue.5
, pp. 463-469
-
-
Chowdhury, R.1
-
15
-
-
84866488967
-
Metabolomics in cancer: A bench-to-bedside intersection
-
Claudino, W.M., et al. 2012. Metabolomics in cancer: A bench-to-bedside intersection. Critical Reviews in Oncology Hematology 84(1): 1-7.
-
(2012)
Critical Reviews in Oncology Hematology
, vol.84
, Issue.1
, pp. 1-7
-
-
Claudino, W.M.1
-
16
-
-
84860512005
-
Links between metabolism and cancer
-
1:CAS:528:DC%2BC38XmslOgtrk%3D
-
Dang, C.V. 2012. Links between metabolism and cancer. Genes & Development 26(9): 877-890.
-
(2012)
Genes & Development
, vol.26
, Issue.9
, pp. 877-890
-
-
Dang, C.V.1
-
17
-
-
72049125350
-
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
-
1:CAS:528:DC%2BD1MXhsVGlurzE 19935646
-
Dang, L., et al. 2009. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462(7274): 739-744.
-
(2009)
Nature
, vol.462
, Issue.7274
, pp. 739-744
-
-
Dang, L.1
-
18
-
-
84903698645
-
Targeted cancer therapeutics: Biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors
-
1:CAS:528:DC%2BC2cXpt1Wht7w%3D 23859615
-
Dang, N.H., et al. 2014. Targeted cancer therapeutics: Biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors. Current Pharmaceutical Design 20(15): 2637-2647.
-
(2014)
Current Pharmaceutical Design
, vol.20
, Issue.15
, pp. 2637-2647
-
-
Dang, N.H.1
-
19
-
-
75149148563
-
Q's next: The diverse functions of glutamine in metabolism, cell biology and cancer
-
1:CAS:528:DC%2BD1MXhtlers7fE 19881548
-
DeBerardinis, R.J., and T. Cheng. 2010. Q's next: The diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29(3): 313-324.
-
(2010)
Oncogene
, vol.29
, Issue.3
, pp. 313-324
-
-
Deberardinis, R.J.1
Cheng, T.2
-
20
-
-
37449034854
-
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
-
1:CAS:528:DC%2BD1cXisVOjtQ%3D%3D
-
DeBerardinis, R.J., et al. 2007. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences USA 104(49): 19345-19350.
-
(2007)
Proceedings of the National Academy of Sciences USA
, vol.104
, Issue.49
, pp. 19345-19350
-
-
Deberardinis, R.J.1
-
21
-
-
0028902940
-
Isotopomer analysis of citric acid cycle and gluconeogenesis in rat liver. Reversibility of isocitrate dehydrogenase and involvement of ATP-citrate lyase in gluconeogenesis
-
1:CAS:528:DyaK2MXltlWnsrc%3D 7730304
-
Des Rosiers, C., et al. 1995. Isotopomer analysis of citric acid cycle and gluconeogenesis in rat liver. Reversibility of isocitrate dehydrogenase and involvement of ATP-citrate lyase in gluconeogenesis. Journal of Biological Chemistry 270(17): 10027-10036.
-
(1995)
Journal of Biological Chemistry
, vol.270
, Issue.17
, pp. 10027-10036
-
-
Des Rosiers, C.1
-
22
-
-
84855732698
-
Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids
-
1:CAS:528:DC%2BC38XivVantL8%3D 22364616
-
Duarte, I.F., and A.M. Gil. 2012. Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids. Progress in Nuclear Magnetic Resonance Spectroscopy 62: 51-74.
-
(2012)
Progress in Nuclear Magnetic Resonance Spectroscopy
, vol.62
, pp. 51-74
-
-
Duarte, I.F.1
Gil, A.M.2
-
23
-
-
18844406001
-
Measuring the metabolome: Current analytical technologies
-
1:CAS:528:DC%2BD2MXjsFOnurw%3D 15852128
-
Dunn, W.B., N.J. Bailey, and H.E. Johnson. 2005. Measuring the metabolome: Current analytical technologies. Analyst 130(5): 606-625.
-
(2005)
Analyst
, vol.130
, Issue.5
, pp. 606-625
-
-
Dunn, W.B.1
Bailey, N.J.2
Johnson, H.E.3
-
24
-
-
84890209181
-
Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia
-
1:CAS:528:DC%2BC3sXhvFCjs7fF 24301801
-
Fan, J., et al. 2013. Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia. Molecular systems biology 9: 712.
-
(2013)
Molecular Systems Biology
, vol.9
, pp. 712
-
-
Fan, J.1
-
25
-
-
84902332213
-
Quantitative flux analysis reveals folate-dependent NADPH production
-
1:CAS:528:DC%2BC2cXps1WmtLc%3D 24805240
-
Fan, J., et al. 2014. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510(7504): 298-302.
-
(2014)
Nature
, vol.510
, Issue.7504
, pp. 298-302
-
-
Fan, J.1
-
26
-
-
34247352844
-
Inhibitory effect of tumor cell-derived lactic acid on human T cells
-
1:CAS:528:DC%2BD2sXkvFCitLs%3D 17255361
-
Fischer, K., et al. 2007. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109(9): 3812-3819.
-
(2007)
Blood
, vol.109
, Issue.9
, pp. 3812-3819
-
-
Fischer, K.1
-
27
-
-
0037731447
-
Lactate-sensitive response elements in genes involved in hyaluronan catabolism
-
1:CAS:528:DC%2BD3sXjsVGmsLw%3D 12732217
-
Formby, B., and R. Stern. 2003. Lactate-sensitive response elements in genes involved in hyaluronan catabolism. Biochemical and Biophysical Research Communications 305(1): 203-208.
-
(2003)
Biochemical and Biophysical Research Communications
, vol.305
, Issue.1
, pp. 203-208
-
-
Formby, B.1
Stern, R.2
-
28
-
-
64749116346
-
C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
-
1:CAS:528:DC%2BD1MXhvFKjtrY%3D 19219026
-
Gao, P., et al. 2009. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458(7239): 762-765.
-
(2009)
Nature
, vol.458
, Issue.7239
, pp. 762-765
-
-
Gao, P.1
-
29
-
-
79960029992
-
Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release
-
1:CAS:528:DC%2BC3MXpvVegsbg%3D 21617859
-
Goetze, K., et al. 2011. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. International Journal of Oncology 39(2): 453-463.
-
(2011)
International Journal of Oncology
, vol.39
, Issue.2
, pp. 453-463
-
-
Goetze, K.1
-
30
-
-
33344467760
-
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
-
1:CAS:528:DC%2BD28XitFCht7s%3D 16278308
-
Gottfried, E., et al. 2006. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107(5): 2013-2021.
-
(2006)
Blood
, vol.107
, Issue.5
, pp. 2013-2021
-
-
Gottfried, E.1
-
31
-
-
28544446058
-
Mitochondrial tumour suppressors: A genetic and biochemical update
-
1:CAS:528:DC%2BD2MXht1WitLfE 16327764
-
Gottlieb, E., and I.P. Tomlinson. 2005. Mitochondrial tumour suppressors: A genetic and biochemical update. Nature Reviews Cancer 5(11): 857-866.
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.11
, pp. 857-866
-
-
Gottlieb, E.1
Tomlinson, I.P.2
-
32
-
-
84903489573
-
IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism
-
1:CAS:528:DC%2BC2cXps1Cmurw%3D 24755473
-
Grassian, A.R., et al. 2014. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Research 74(12): 3317-3331.
-
(2014)
Cancer Research
, vol.74
, Issue.12
, pp. 3317-3331
-
-
Grassian, A.R.1
-
33
-
-
63549121490
-
NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer
-
1:CAS:528:DC%2BD1MXksVSkt7k%3D 19321346
-
Hayes, J.D., and M. McMahon. 2009. NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer. Trends in Biochemical Sciences 34(4): 176-188.
-
(2009)
Trends in Biochemical Sciences
, vol.34
, Issue.4
, pp. 176-188
-
-
Hayes, J.D.1
McMahon, M.2
-
34
-
-
84883497454
-
Glutamine and cancer: Cell biology, physiology, and clinical opportunities
-
1:CAS:528:DC%2BC3sXhsVenu7bL 23999442
-
Hensley, C.T., A.T. Wasti, and R.J. DeBerardinis. 2013. Glutamine and cancer: Cell biology, physiology, and clinical opportunities. The Journal of Clinical Investigation 123(9): 3678-3684.
-
(2013)
The Journal of Clinical Investigation
, vol.123
, Issue.9
, pp. 3678-3684
-
-
Hensley, C.T.1
Wasti, A.T.2
Deberardinis, R.J.3
-
35
-
-
81155126061
-
Lactate: A metabolic key player in cancer
-
1:CAS:528:DC%2BC3MXhsVKhu7jK 22084445
-
Hirschhaeuser, F., U.G. Sattler, and W. Mueller-Klieser. 2011. Lactate: A metabolic key player in cancer. Cancer Research 71(22): 6921-6925.
-
(2011)
Cancer Research
, vol.71
, Issue.22
, pp. 6921-6925
-
-
Hirschhaeuser, F.1
Sattler, U.G.2
Mueller-Klieser, W.3
-
36
-
-
0029591465
-
Glutamine metabolism in AS-30D hepatoma cells. Evidence for its conversion into lipids via reductive carboxylation
-
1:CAS:528:DyaK28Xislektg%3D%3D 8751155
-
Holleran, A.L., et al. 1995. Glutamine metabolism in AS-30D hepatoma cells. Evidence for its conversion into lipids via reductive carboxylation. Molecular and Cellular Biochemistry 152(2): 95-101.
-
(1995)
Molecular and Cellular Biochemistry
, vol.152
, Issue.2
, pp. 95-101
-
-
Holleran, A.L.1
-
37
-
-
52649107626
-
Cancer cell metabolism: Warburg and beyond
-
1:CAS:528:DC%2BD1cXhtFCqs7jK 18775299
-
Hsu, P.P., and D.M. Sabatini. 2008. Cancer cell metabolism: Warburg and beyond. Cell 134(5): 703-707.
-
(2008)
Cell
, vol.134
, Issue.5
, pp. 703-707
-
-
Hsu, P.P.1
Sabatini, D.M.2
-
38
-
-
77952212178
-
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
-
1:CAS:528:DC%2BC3cXlsFWhsbo%3D
-
Hu, W., et al. 2010. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proceedings of the National Academy of Sciences USA 107(16): 7455-7460.
-
(2010)
Proceedings of the National Academy of Sciences USA
, vol.107
, Issue.16
, pp. 7455-7460
-
-
Hu, W.1
-
39
-
-
79955492012
-
Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
-
1:CAS:528:DC%2BC3MXltlGjtro%3D 21482715
-
Inami, Y., et al. 2011. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. Journal of Cell Biology 193(2): 275-284.
-
(2011)
Journal of Cell Biology
, vol.193
, Issue.2
, pp. 275-284
-
-
Inami, Y.1
-
40
-
-
84861420588
-
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
-
1:CAS:528:DC%2BC38Xnt1KgtL8%3D 22628656
-
Jain, M., et al. 2012. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336(6084): 1040-1044.
-
(2012)
Science
, vol.336
, Issue.6084
, pp. 1040-1044
-
-
Jain, M.1
-
41
-
-
84885944468
-
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
-
1:CAS:528:DC%2BC3sXhslCjt7zN
-
Jaramillo, M.C., and D.D. Zhang. 2013. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes & Development 27(20): 2179-2191.
-
(2013)
Genes & Development
, vol.27
, Issue.20
, pp. 2179-2191
-
-
Jaramillo, M.C.1
Zhang, D.D.2
-
42
-
-
78651318867
-
Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression
-
1:CAS:528:DC%2BC3MXjsFSqsQ%3D%3D 21168877
-
Jentzmik, F., et al. 2011. Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. Journal of Urology 185(2): 706-711.
-
(2011)
Journal of Urology
, vol.185
, Issue.2
, pp. 706-711
-
-
Jentzmik, F.1
-
43
-
-
84884192379
-
Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer
-
1:CAS:528:DC%2BC3sXhsV2ru77N 24069390
-
Kennedy, K.M., et al. 2013. Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. PLoS One 8(9): e75154.
-
(2013)
PLoS One
, vol.8
, Issue.9
, pp. 75154
-
-
Kennedy, K.M.1
-
44
-
-
84862776918
-
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
-
Koivunen, P., et al. 2012. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483(7390): 485-488.
-
(2012)
Nature
, vol.483
, Issue.7390
, pp. 485-488
-
-
Koivunen, P.1
-
45
-
-
80052338863
-
Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia
-
1:CAS:528:DC%2BC3MXhtFCktb3M 21852960
-
Kung, H.N., J.R. Marks, and J.T. Chi. 2011. Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genetics 7(8): e1002229.
-
(2011)
PLoS Genetics
, vol.7
, Issue.8
, pp. 1002229
-
-
Kung, H.N.1
Marks, J.R.2
Chi, J.T.3
-
46
-
-
84920448829
-
NMR spectroscopy for metabolomics and metabolic profiling
-
Larive, C.K., G.A. Barding, and M.M. Dinges. 2014. NMR spectroscopy for metabolomics and metabolic profiling. Analytical chemistry 87(1): 133-146.
-
(2014)
Analytical Chemistry
, vol.87
, Issue.1
, pp. 133-146
-
-
Larive, C.K.1
Barding, G.A.2
Dinges, M.M.3
-
47
-
-
79960384696
-
Mass spectrometry strategies in metabolomics
-
1:CAS:528:DC%2BC3MXovFCksbY%3D 21632543
-
Lei, Z., D.V. Huhman, and L.W. Sumner. 2011. Mass spectrometry strategies in metabolomics. Journal of Biological Chemistry 286(29): 25435-25442.
-
(2011)
Journal of Biological Chemistry
, vol.286
, Issue.29
, pp. 25435-25442
-
-
Lei, Z.1
Huhman, D.V.2
Sumner, L.W.3
-
48
-
-
84890021455
-
Review of mass spectrometry-based metabolomics in cancer research
-
1:CAS:528:DC%2BC3sXhvV2rsLfL
-
Liesenfeld, D.B., et al. 2013. Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiology Biomarkers & Prevention 22(12): 2182-2201.
-
(2013)
Cancer Epidemiology Biomarkers & Prevention
, vol.22
, Issue.12
, pp. 2182-2201
-
-
Liesenfeld, D.B.1
-
49
-
-
84881177291
-
Serine, glycine and one-carbon units: Cancer metabolism in full circle
-
1:CAS:528:DC%2BC3sXhtVGrsLzE 23822983
-
Locasale, J.W. 2013. Serine, glycine and one-carbon units: Cancer metabolism in full circle. Nature Reviews Cancer 13(8): 572-583.
-
(2013)
Nature Reviews Cancer
, vol.13
, Issue.8
, pp. 572-583
-
-
Locasale, J.W.1
-
50
-
-
0037189542
-
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis
-
1:CAS:528:DC%2BD38XltF2nsr4%3D 11943784
-
Lu, H., R.A. Forbes, and A. Verma. 2002. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. Journal of Biological Chemistry 277(26): 23111-23115.
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.26
, pp. 23111-23115
-
-
Lu, H.1
Forbes, R.A.2
Verma, A.3
-
51
-
-
84868117861
-
Metabolism of [U-13 C]glucose in human brain tumors in vivo
-
1:CAS:528:DC%2BC38XhsFGqtLrO 22419606
-
Maher, E.A., et al. 2012. Metabolism of [U-13 C]glucose in human brain tumors in vivo. NMR in Biomedicine 25(11): 1234-1244.
-
(2012)
NMR in Biomedicine
, vol.25
, Issue.11
, pp. 1234-1244
-
-
Maher, E.A.1
-
52
-
-
84856014884
-
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
-
1:CAS:528:DC%2BC3MXhsV2gt7fP
-
Metallo, C.M., et al. 2012. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481(7381): 380-384.
-
(2012)
Nature
, vol.481
, Issue.7381
, pp. 380-384
-
-
Metallo, C.M.1
-
53
-
-
84878659022
-
Sum of the parts: Mass spectrometry-based metabolomics
-
1:CAS:528:DC%2BC3sXjtVCms7s%3D 23442130
-
Milne, S.B., et al. 2013. Sum of the parts: Mass spectrometry-based metabolomics. Biochemistry 52(22): 3829-3840.
-
(2013)
Biochemistry
, vol.52
, Issue.22
, pp. 3829-3840
-
-
Milne, S.B.1
-
54
-
-
33847367741
-
Energy metabolism in tumor cells
-
1:CAS:528:DC%2BD2sXjslait7g%3D 17302740
-
Moreno-Sanchez, R., et al. 2007. Energy metabolism in tumor cells. FEBS Journal 274(6): 1393-1418.
-
(2007)
FEBS Journal
, vol.274
, Issue.6
, pp. 1393-1418
-
-
Moreno-Sanchez, R.1
-
55
-
-
84855987831
-
Reductive carboxylation supports growth in tumour cells with defective mitochondria
-
1:CAS:528:DC%2BC3MXhsV2gt73F
-
Mullen, A.R., et al. 2012. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481(7381): 385-388.
-
(2012)
Nature
, vol.481
, Issue.7381
, pp. 385-388
-
-
Mullen, A.R.1
-
56
-
-
84902343371
-
Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects
-
1:CAS:528:DC%2BC2cXosl2htb0%3D 24857658
-
Mullen, A.R., et al. 2014. Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects. Cell Reports 7(5): 1679-1690.
-
(2014)
Cell Reports
, vol.7
, Issue.5
, pp. 1679-1690
-
-
Mullen, A.R.1
-
57
-
-
54549091125
-
Systems biology: Metabonomics
-
1:CAS:528:DC%2BD1cXht1yju7zN 18948945
-
Nicholson, J.K., and J.C. Lindon. 2008. Systems biology: Metabonomics. Nature 455(7216): 1054-1056.
-
(2008)
Nature
, vol.455
, Issue.7216
, pp. 1054-1056
-
-
Nicholson, J.K.1
Lindon, J.C.2
-
59
-
-
84858055067
-
Recent advances in metabolomics in oncology
-
O'Connell, T.M. 2012. Recent advances in metabolomics in oncology. Bioanalysis 4(4): 431-451.
-
(2012)
Bioanalysis
, vol.4
, Issue.4
, pp. 431-451
-
-
O'Connell, T.M.1
-
60
-
-
80054772589
-
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma
-
1:CAS:528:DC%2BC3MXhtlKrtrbF 22014576
-
Ooi, A., et al. 2011. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20(4): 511-523.
-
(2011)
Cancer Cell
, vol.20
, Issue.4
, pp. 511-523
-
-
Ooi, A.1
-
61
-
-
33846109344
-
Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics
-
1:CAS:528:DC%2BD2sXlsFOisA%3D%3D 16955259
-
Pan, Z., and D. Raftery. 2007. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Analytical and Bioanalytical Chemistry 387(2): 525-527.
-
(2007)
Analytical and Bioanalytical Chemistry
, vol.387
, Issue.2
, pp. 525-527
-
-
Pan, Z.1
Raftery, D.2
-
62
-
-
52949127312
-
An integrated genomic analysis of human glioblastoma multiforme
-
1:CAS:528:DC%2BD1cXhtFCrtLrE 18772396
-
Parsons, D.W., et al. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897): 1807-1812.
-
(2008)
Science
, vol.321
, Issue.5897
, pp. 1807-1812
-
-
Parsons, D.W.1
-
63
-
-
84858790233
-
Metabolomics: The apogee of the omics trilogy
-
1:CAS:528:DC%2BC38XksVent78%3D 22436749
-
Patti, G.J., O. Yanes, and G. Siuzdak. 2012. Metabolomics: The apogee of the omics trilogy. Nature Reviews Molecular Cell Biology 13(4): 263-269.
-
(2012)
Nature Reviews Molecular Cell Biology
, vol.13
, Issue.4
, pp. 263-269
-
-
Patti, G.J.1
Yanes, O.2
Siuzdak, G.3
-
64
-
-
26444570010
-
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations
-
1:CAS:528:DC%2BD2MXmt1ert78%3D 15987702
-
Pollard, P.J., et al. 2005. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Human Molecular Genetics 14(15): 2231-2239.
-
(2005)
Human Molecular Genetics
, vol.14
, Issue.15
, pp. 2231-2239
-
-
Pollard, P.J.1
-
65
-
-
80051923932
-
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
-
1:CAS:528:DC%2BC3MXhtVOku7rL 21760589
-
Possemato, R., et al. 2011. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476(7360): 346-350.
-
(2011)
Nature
, vol.476
, Issue.7360
, pp. 346-350
-
-
Possemato, R.1
-
66
-
-
84865520089
-
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
-
1:CAS:528:DC%2BC38XhtFWmt7bL 22763442
-
Sasaki, M., et al. 2012. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488(7413): 656-659.
-
(2012)
Nature
, vol.488
, Issue.7413
, pp. 656-659
-
-
Sasaki, M.1
-
67
-
-
77957771067
-
IDH1 mutations are detected in 6.6 % of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status
-
1:CAS:528:DC%2BC3MXhtFGktbc%3D 20805365
-
Schnittger, S., et al. 2010. IDH1 mutations are detected in 6.6 % of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status. Blood 116(25): 5486-5496.
-
(2010)
Blood
, vol.116
, Issue.25
, pp. 5486-5496
-
-
Schnittger, S.1
-
68
-
-
84869009687
-
How cancer metabolism is tuned for proliferation and vulnerable to disruption
-
1:CAS:528:DC%2BC38Xhs1Ogt77F 23151579
-
Schulze, A., and A.L. Harris. 2012. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491(7424): 364-373.
-
(2012)
Nature
, vol.491
, Issue.7424
, pp. 364-373
-
-
Schulze, A.1
Harris, A.L.2
-
69
-
-
84902182150
-
Mechanism and function of oxidative reversal of DNA and RNA methylation
-
1:CAS:528:DC%2BC2cXhtFOhtrnP 24905787
-
Shen, L., et al. 2014. Mechanism and function of oxidative reversal of DNA and RNA methylation. Annual Review of Biochemistry 83: 585-614.
-
(2014)
Annual Review of Biochemistry
, vol.83
, pp. 585-614
-
-
Shen, L.1
-
70
-
-
84908402760
-
L-2-Hydroxyglutarate: An epigenetic modifier and putative oncometabolite in renal cancer
-
1:CAS:528:DC%2BC2cXhvVyju7nF 25182153
-
Shim, E.H., et al. 2014. L-2-Hydroxyglutarate: An epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discovery 4(11): 1290-1298.
-
(2014)
Cancer Discovery
, vol.4
, Issue.11
, pp. 1290-1298
-
-
Shim, E.H.1
-
71
-
-
75149138761
-
Prolyl hydroxylases and therapeutics
-
1:CAS:528:DC%2BC3cXitVahsbw%3D
-
Smith, T.G., and N.P. Talbot. 2010. Prolyl hydroxylases and therapeutics. Antioxidants & Redox Signaling 12(4): 431-433.
-
(2010)
Antioxidants & Redox Signaling
, vol.12
, Issue.4
, pp. 431-433
-
-
Smith, T.G.1
Talbot, N.P.2
-
72
-
-
57449097020
-
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
-
2582933 1:CAS:528:DC%2BD1cXhsVKgu7rI 19033663
-
Sonveaux, P., et al. 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. The Journal of Clinical Investigation 118(12): 3930-3942.
-
(2008)
The Journal of Clinical Investigation
, vol.118
, Issue.12
, pp. 3930-3942
-
-
Sonveaux, P.1
-
73
-
-
59449097019
-
Clinical applications of metabolomics in oncology: A review
-
1:CAS:528:DC%2BD1MXlvFeksw%3D%3D 19147747
-
Spratlin, J.L., N.J. Serkova, and S.G. Eckhardt. 2009. Clinical applications of metabolomics in oncology: A review. Clinical Cancer Research 15(2): 431-440.
-
(2009)
Clinical Cancer Research
, vol.15
, Issue.2
, pp. 431-440
-
-
Spratlin, J.L.1
Serkova, N.J.2
Eckhardt, S.G.3
-
74
-
-
60149091657
-
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
-
1:CAS:528:DC%2BD1MXhslCnt70%3D 19212411
-
Sreekumar, A., et al. 2009. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231): 910-914.
-
(2009)
Nature
, vol.457
, Issue.7231
, pp. 910-914
-
-
Sreekumar, A.1
-
75
-
-
0036347515
-
Lactate stimulates fibroblast expression of hyaluronan and CD44: The Warburg effect revisited
-
1:CAS:528:DC%2BD38XjtFyisrk%3D 11978005
-
Stern, R., et al. 2002. Lactate stimulates fibroblast expression of hyaluronan and CD44: The Warburg effect revisited. Experimental Cell Research 276(1): 24-31.
-
(2002)
Experimental Cell Research
, vol.276
, Issue.1
, pp. 24-31
-
-
Stern, R.1
-
76
-
-
77952227625
-
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species
-
1:CAS:528:DC%2BC3cXlsFWhsbs%3D
-
Suzuki, S., et al. 2010. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proceedings of the National Academy of Sciences USA 107(16): 7461-7466.
-
(2010)
Proceedings of the National Academy of Sciences USA
, vol.107
, Issue.16
, pp. 7461-7466
-
-
Suzuki, S.1
-
77
-
-
12344297755
-
Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas
-
1:CAS:528:DC%2BD2MXkvFKlsQ%3D%3D 15663956
-
Szeliga, M., et al. 2005. Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas. Neuroscience Letters 374(3): 171-173.
-
(2005)
Neuroscience Letters
, vol.374
, Issue.3
, pp. 171-173
-
-
Szeliga, M.1
-
78
-
-
84867130104
-
Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth
-
van den Heuvel, A.P., et al. 2012. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biology & Therapy 13(12): 1185-1194.
-
(2012)
Cancer Biology & Therapy
, vol.13
, Issue.12
, pp. 1185-1194
-
-
Van Den Heuvel, A.P.1
-
79
-
-
80052242132
-
Targeting cancer metabolism: A therapeutic window opens
-
1:CAS:528:DC%2BC3MXhtFSltb3J 21878982
-
Vander Heiden, M.G. 2011. Targeting cancer metabolism: A therapeutic window opens. Nature reviews Drug discovery 10(9): 671-684.
-
(2011)
Nature Reviews Drug Discovery
, vol.10
, Issue.9
, pp. 671-684
-
-
Vander Heiden, M.G.1
-
80
-
-
66249108601
-
Understanding the Warburg effect: The metabolic requirements of cell proliferation
-
1:CAS:528:DC%2BD1MXmtVKlsbg%3D 19460998
-
Vander Heiden, M.G., L.C. Cantley, and C.B. Thompson. 2009. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324(5930): 1029-1033.
-
(2009)
Science
, vol.324
, Issue.5930
, pp. 1029-1033
-
-
Vander Heiden, M.G.1
Cantley, L.C.2
Thompson, C.B.3
-
81
-
-
79953329777
-
Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis
-
1:CAS:528:DC%2BC3MXktVOjtLg%3D 21300765
-
Vegran, F., et al. 2011. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis. Cancer Research 71(7): 2550-2560.
-
(2011)
Cancer Research
, vol.71
, Issue.7
, pp. 2550-2560
-
-
Vegran, F.1
-
82
-
-
12444279265
-
On the origin of cancer cells
-
1:STN:280:DyaG28%2FltV2ktQ%3D%3D 13298683
-
Warburg, O. 1956. On the origin of cancer cells. Science 123(3191): 309-314.
-
(1956)
Science
, vol.123
, Issue.3191
, pp. 309-314
-
-
Warburg, O.1
-
84
-
-
84858604270
-
Metabolic reprogramming: A cancer hallmark even warburg did not anticipate
-
1:CAS:528:DC%2BC38Xkt1ylsbc%3D 22439925
-
Ward, P.S., and C.B. Thompson. 2012a. Metabolic reprogramming: A cancer hallmark even warburg did not anticipate. Cancer Cell 21(3): 297-308.
-
(2012)
Cancer Cell
, vol.21
, Issue.3
, pp. 297-308
-
-
Ward, P.S.1
Thompson, C.B.2
-
86
-
-
77649305610
-
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
-
1:CAS:528:DC%2BC3cXlsVWqtLg%3D 20171147
-
Ward, P.S., et al. 2010. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17(3): 225-234.
-
(2010)
Cancer Cell
, vol.17
, Issue.3
, pp. 225-234
-
-
Ward, P.S.1
-
87
-
-
77954197821
-
High-throughput and multiplexed LC/MS/MRM method for targeted metabolomics
-
1:CAS:528:DC%2BC3cXmvF2qsb4%3D 20524683
-
Wei, R., G. Li, and A.B. Seymour. 2010. High-throughput and multiplexed LC/MS/MRM method for targeted metabolomics. Analytical Chemistry 82(13): 5527-5533.
-
(2010)
Analytical Chemistry
, vol.82
, Issue.13
, pp. 5527-5533
-
-
Wei, R.1
Li, G.2
Seymour, A.B.3
-
88
-
-
77952737658
-
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
-
1:CAS:528:DC%2BC3cXmsFWmurs%3D
-
Weinberg, F., et al. 2010. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proceedings of the National Academy of Sciences USA 107(19): 8788-8793.
-
(2010)
Proceedings of the National Academy of Sciences USA
, vol.107
, Issue.19
, pp. 8788-8793
-
-
Weinberg, F.1
-
89
-
-
84921340449
-
Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism
-
Wen, H., et al. 2014. Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism. Journal of Neurochemistry 132(2): 183-193.
-
(2014)
Journal of Neurochemistry
, vol.132
, Issue.2
, pp. 183-193
-
-
Wen, H.1
-
90
-
-
57749088701
-
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
-
1:CAS:528:DC%2BD1cXhsV2rtL%2FK
-
Wise, D.R., et al. 2008. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences USA 105(48): 18782-18787.
-
(2008)
Proceedings of the National Academy of Sciences USA
, vol.105
, Issue.48
, pp. 18782-18787
-
-
Wise, D.R.1
-
91
-
-
83755178091
-
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability
-
1:CAS:528:DC%2BC3MXhs1GjsbvP
-
Wise, D.R., et al. 2011. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proceedings of the National Academy of Sciences USA 108(49): 19611-19616.
-
(2011)
Proceedings of the National Academy of Sciences USA
, vol.108
, Issue.49
, pp. 19611-19616
-
-
Wise, D.R.1
-
92
-
-
33644828213
-
Metabolomics: The principles and potential applications to transplantation
-
1:CAS:528:DC%2BD2MXhtlGns7zI 16302993
-
Wishart, D.S. 2005. Metabolomics: The principles and potential applications to transplantation. American Journal of Transplantation 5(12): 2814-2820.
-
(2005)
American Journal of Transplantation
, vol.5
, Issue.12
, pp. 2814-2820
-
-
Wishart, D.S.1
-
93
-
-
84876148784
-
HMDB 3.0-The human metabolome database in 2013
-
1:CAS:528:DC%2BC38XhvV2ktrnP 23161693
-
Wishart, D.S., et al. 2013. HMDB 3.0-the human metabolome database in 2013. Nucleic acids research 41: D801-D807.
-
(2013)
Nucleic Acids Research
, vol.41
, pp. 801-D807
-
-
Wishart, D.S.1
-
94
-
-
78651463452
-
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases
-
1:CAS:528:DC%2BC3MXpvValsQ%3D%3D 21251613
-
Xu, W., et al. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19(1): 17-30.
-
(2011)
Cancer Cell
, vol.19
, Issue.1
, pp. 17-30
-
-
Xu, W.1
-
95
-
-
60849115270
-
IDH1 and IDH2 mutations in gliomas
-
1:CAS:528:DC%2BD1MXitFWru7o%3D 19228619
-
Yan, H., et al. 2009. IDH1 and IDH2 mutations in gliomas. New England Journal of Medicine 360(8): 765-773.
-
(2009)
New England Journal of Medicine
, vol.360
, Issue.8
, pp. 765-773
-
-
Yan, H.1
-
96
-
-
84867562009
-
IDH1 and IDH2 mutations in tumorigenesis: Mechanistic insights and clinical perspectives
-
1:CAS:528:DC%2BC38XhsFahu73E 23071358
-
Yang, H., et al. 2012. IDH1 and IDH2 mutations in tumorigenesis: Mechanistic insights and clinical perspectives. Clinical Cancer Research 18(20): 5562-5571.
-
(2012)
Clinical Cancer Research
, vol.18
, Issue.20
, pp. 5562-5571
-
-
Yang, H.1
-
97
-
-
84883513587
-
Oncometabolites: Linking altered metabolism with cancer
-
1:CAS:528:DC%2BC3sXhsVenu7bP 23999438
-
Yang, M., T. Soga, and P.J. Pollard. 2013. Oncometabolites: Linking altered metabolism with cancer. The Journal of Clinical Investigation 123(9): 3652-3658.
-
(2013)
The Journal of Clinical Investigation
, vol.123
, Issue.9
, pp. 3652-3658
-
-
Yang, M.1
Soga, T.2
Pollard, P.J.3
-
98
-
-
84856087055
-
Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis
-
1:CAS:528:DC%2BC38XhtFKgsbw%3D 22225612
-
Zhang, W.C., et al. 2012. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148(1-2): 259-272.
-
(2012)
Cell
, vol.148
, Issue.1-2
, pp. 259-272
-
-
Zhang, W.C.1
-
99
-
-
84881475400
-
NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis
-
1:CAS:528:DC%2BC3sXhtVKrtrnE 23828598
-
Zhang, A.H., et al. 2013. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis. Magnetic Resonance in Chemistry 51(9): 549-556.
-
(2013)
Magnetic Resonance in Chemistry
, vol.51
, Issue.9
, pp. 549-556
-
-
Zhang, A.H.1
-
100
-
-
64849098267
-
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha
-
1:CAS:528:DC%2BD1MXktFals7g%3D 19359588
-
Zhao, S., et al. 2009. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324(5924): 261-265.
-
(2009)
Science
, vol.324
, Issue.5924
, pp. 261-265
-
-
Zhao, S.1
|